AI Proteins, Inc. — Form D
AI Proteins, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-04. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-04-04
- Form: D
- Accession: 0001903127-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Investors: 8
- Date of first sale: 2024-03-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-509608
Issuer
- Name: AI Proteins, Inc.
- CIK: 0001903127
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 20 OVERLAND STREET, BOSTON, MA, 02215
- Phone: 617-412-6117
Officers, directors & promoters (25)
| Name | Role | Location |
|---|
| Chris Bahl | Director | Boston, MA |
| Noah Beerman | Director | Boston, MA |
| Drew Dennison | Director | St. Louis, MO |
| Bruce Evans | Director | Boston, MA |
| Todd Kaloudis | Director | Boston, MA |
| Malcolm Salter | Director | Boston, MA |
| Bobby Sandage | Director | Boston, MA |
| Chris Bahl | Executive Officer | Boston, MA |
| Noah Beerman | Executive Officer | Boston, MA |
| Wendy Dwyer | Executive Officer | Boston, MA |
| Julia A Novina | Executive Officer | Boston, MA |
| Mark Alles | Director | Culver City, CA |
| Carl A Novina | Director | Andover, MA |
| Elena A Prokupets | Director | Cambridge, MA |
| Arthur A Becker | Director | Cambridge, MA |
| Dominique A Verhelle | Director | Cambridge, MA |
| Marc A Cohen | Director | Cambridge, MA |
| Marc A Cohen | Executive Officer | Cambridge, MA |
| Drew A Dennison | Director | Cambridge, MA |
| Malcolm A Salter | Director | Cambridge, MA |
| Bill A McKee | Director | Andover, MA |
| Geoff A Meyerson | Director | Andover, MA |
| Namandje A Bumpus | Director | Andover, MA |
| Chris A Bahl | Director | Andover, MA |
| Chris A Bahl | Executive Officer | Andover, MA |
Other filings by this issuer (2)
More